2DG: Dr Reddy’s Releases Important Information Regarding Anti-COVID-19 Drug Developed by DRDO; Commercial Launch & Supply to Commence in Mid-June
Dr Reddy’s on Wednesday released important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories. The anti-COVID-19 drug is expected to lunch commercially in mid-June.
Dr Reddy’s releases important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories#COVID19 pic.twitter.com/yXz0wPzeev
— ANI (@ANI) May 19, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on May 19, 2021 09:26 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
